Journal of the Pancreas is rated as the top journal on Islet cell carcinoma. Journal of the pancreas has got its uniqueness in publishing the ingenious and the most upgraded research information in the form of editorials and review articles.
Islet cell carcinoma is an uncommon cancer of the endocrine pancreas. It accounts for approximately 1.3% of pancreatic cancer. It is also known as or nesidioblastoma. Pancreatic islet cell tumors can be benign or malignant. Islet cells produce many different hormones; most tumors release only one hormone that leads to specific symptoms. There are different types of islet cell tumor such as: Gastrinomas (Zollinger-Ellison syndrome), Glucagonomas, Insulinomas. Islet cell tumors are treatable even after they have metastasized. Symptoms include sweating, Headache, Hunger, anxiety, Double or blurry vision, pounding heartbeat, Diarrhea, Ulcers in the stomach and small bowel, Vomiting blood etc.
Journal of the Pancreas has been acquired and being published by one of the leading Open Access publishers in the world i.e. OMICS International. OMICS International has been successful in managing more than 700+ peer-reviewed journals with the help of 50,000+ editorial board members, serving the requirements of 15 million readers. Along with open access publication, OMICS Group has been successful in organizing International conferences around the globe annually. With a vision to make healthcare and scientific information open access OMICS Group has team up with more than 100 renowned associations worldwide.
Last date updated on June, 2014